Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Pharmaceutical R&D

Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach

Teuku Ryan Apr 9, 2026 0

Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…

Read More
Pharmaceutical R&D

Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline

Teuku Ryan Apr 8, 2026 0

Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…

Read More
Pharmaceutical R&D

Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109

Teuku Ryan Apr 7, 2026 0

Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…

Read More
Pharmaceutical R&D

Canada Invests C$79 Million in Aspect Biosystems to Accelerate Development of Bioengineered Cellular Medicines for Endocrine and Metabolic Diseases

Teuku Ryan Apr 6, 2026 0

Vancouver, BC – Aspect Biosystems, a pioneering company in the field of bioengineered cellular medicines, has received a significant C$79…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Apr 5, 2026 0

Ancient Swift-Footed Predator Unearthed in Triassic Britain: A Glimpse into Pre-Extinction Ecosystems In a remarkable discovery that sheds new light…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization

Reynand Amr Wu Mar 29, 2026 0

Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…

Read More
Pharmaceutical R&D

Earendil Labs Secures $787 Million to Accelerate AI-Driven Drug Discovery and Expand Robust Pipeline

Teuku Ryan Mar 23, 2026 0

Earendil Labs, a burgeoning biotechnology firm at the forefront of artificial intelligence (AI)-powered drug discovery, has announced a significant financial…

Read More
Clinical Diagnostics & Pathology

Vitestro Secures $70 Million to Revolutionize Blood Collection with Autonomous Robotic Phlebotomy, Poised for Global Expansion

Reynand Amr Wu Mar 22, 2026 0

Vitestro, a pioneering Dutch medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Mar 21, 2026 0

Ancient Apex Predator Unearthed: Triassic "Galahad" Rewrites Early Crocodile Evolution in Britain A groundbreaking paleontological discovery in Gloucester, United Kingdom,…

Read More
Pharmaceutical R&D

Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline

Teuku Ryan Mar 18, 2026 0

Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…

Read More

Posts pagination

1 … 3 4 5
Quantum Sensing Breakthrough at University at Buffalo May Finally Reveal the Secrets of AltermagnetsSilent Synapses in the Adult Brain Reveal a Hidden Reserve for Lifelong Learning and Memory PlasticityThe Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line DevelopmentImmune System Response in the Brain Identified as Primary Cause for Early Olfactory Loss in Alzheimer’s Disease
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ